5 Biotech Stocks To Buy According To Chinese Billionaire Lei Zhang

3. I-Mab (NASDAQ:IMAB)

Hillhouse Capital Management’s Stake Value: $520,685,000

Percentage of Hillhouse Capital Management’s 13F Portfolio: 6.80%

Number of Hedge Fund Holders: 18

I-Mab (NASDAQ:IMAB) is one of the top biotech stocks to buy according to billionaire Lei Zhang, with his hedge fund boosting its position in the company by 9% in Q3, holding a $520.6 million position. I-Mab (NASDAQ:IMAB) is a Chinese biotech company working on the development of therapies for immuno-oncology and autoimmune diseases. 

I-Mab (NASDAQ:IMAB) announced on October 26 a partnership with Sinopharm Group Co., Ltd. (OTC:SHTDY) to improve its commercial capabilities and accelerate its commercialization transformation. 

According to the Q3 database of 867 elite hedge funds monitored by Insider Monkey, 18 funds reported owning stakes in I-Mab (NASDAQ:IMAB), worth $837.7 million. One of the leading I-Mab (NASDAQ:IMAB) stakeholders is Adage Capital Management, with the hedge fund elevating its position in the company by 46% as of September 2021, holding a $86.9 million stake.